Brevetti EPO No.3515418 2021.04.14
Brevetti EPO
(10) Registration Number and Date
2021000405 2021.07.13
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2021/000405 2017.09.21
(40) Publication Number and Date
SM /T/2021/000405 2021.07.13
(30) Priority Details
GB 201616116
2016.09.22
(51) IPC Classes
(72) Inventor
(IT) FRIGAULT, Melanie Mae : AstraZeneca35 Gatehouse Drive, Waltham, MA 02451, US
(74) Representative Name
(IT) BUSCA, Andrea : Strada Caiese, 30, 47891 Dogana RSM, SM
(54) Title
(IT) USO DI INIBITORI DI C-MET PER TRATTARE CANCRI CHE OSPITANO MUTAZIONI DI MET
(EN) USE OF C-MET INHIBITORS TO TREAT CANCERS HARBOURING MET MUTATIONS
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2021.09.22
Event NameDateStatus
Filing2017.09.21Filed
Brevetto EPO concesso2021.07.13Published
Ricevuta pagamento annualita 52021.09.20Payed
Ricevuta pagamento annualita 62022.08.31Payed
Ricevuta pagamento annualita 72023.09.28Payed
Ricevuta pagamento annualita 82024.08.29Payed